[1. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006; 47:1094-120.10.1111/j.1528-1167.2006.00585.x]Search in Google Scholar
[2. Goodridge PMG, Shorvon SD. Epileptic seizures in a population of 6000. 2 Treatment and prognosis. Brit Med. 1983; l:645-7.10.1136/bmj.287.6393.645]Search in Google Scholar
[3. Hart YM, Sander J WAS, Johnson AL, Shorvon SD. National general practice study of epilepsy: recurrence after a first seizure. Lancet. 1990; 1:1271-4.10.1016/0140-6736(90)92960-P]Search in Google Scholar
[4. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998; 39(1):5-17.10.1111/j.1528-1157.1998.tb01268.x]Open DOISearch in Google Scholar
[5. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983; 33: 1487-9.10.1212/WNL.33.11.1487]Open DOISearch in Google Scholar
[6. Genton P, Gelisse R, Thomas P., Dravet C. Do Caramazepine and Pheniton aggravate juvenile myclonic epilepsy? Neurology. 2000; 55:1106-9.10.1212/WNL.55.8.1106]Open DOISearch in Google Scholar
[7. Stefan H, Wang Y, Pauli E, Schmidt B. A new approach in anti-epileptic drug evaluation. Eur J Neurol. 2004; 11: 467-73.10.1111/j.1468-1331.2004.00812.x]Open DOISearch in Google Scholar
[8. Corda D, Gelisse P, Dravet C, Baldy-Mouiner M. Incidence of drug-induced aggravation in Benign epilepsy with centotemporal spikes. Epilepsia. 2001; 42: 754-59.10.1046/j.1528-1157.2001.30000.x]Search in Google Scholar
[9. Horn C, Ater S, Hurst D. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol. 1986; 2:340-5.10.1016/0887-8994(86)90074-3]Open DOISearch in Google Scholar
[10. Beaumanoir A. The Landay-Kleffner syndroe. In: Roger J, Bureau M, Dravet C, Genton CP, Tassinari CA, Wolf P, editors. Epilepsy syndromes in infancy, childhood and adolescence. 2nd ed. Paris:John Libbey, 1992. p. 231-43.]Search in Google Scholar
[11. Tassinari C, Bureau M, Dravet C. Epilepsy with continuous spikes and waves during slow sleep: otherwise with described with electrical status epilepticus during slow sleep (ESES) In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, editors. Epilepsy syndromes in infancy, childhood and adolescence. 2nd ed. Paris:John Libbey, 1992. p. 254-56.]Search in Google Scholar
[12. Rho J M, Shankar R. The pharmacological basis of antiepileptic drugs action. Epilepsia. 1999; 40:1471-83.10.1111/j.1528-1157.1999.tb02029.x10565572]Search in Google Scholar
[13. Macdonald RL, Meldrum BS. Principles of antiepileptic drug action. In: Levy R, Mattson R, Meldrum B. Penry JK, Dreifuss FE, editors. Antiepileptic drugs. NewYork;Raven Press, 1989. p. 59-83.]Search in Google Scholar
[14. Granger P, Biton B, Faure C., Vige X, Depoortere H, Graham D, Langer SZ, Scatton B, Avenet P. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol Pharmacol. 1995; 47:1189-96.]Search in Google Scholar
[15. Sramek J, Zarotsky V, Cutler N. Generalised anxiety disorder: treatment options. Drugs. 2002; 62:1635-48. 10.2165/00003495-200262110-00005]Search in Google Scholar
[16. Clemens B, Piros P, Bessenyei M, Hollody K. Lamotrigine decreases EEG synchronization in a use-dependent manner in patients with idiopathic generalized epilepsy. Clin Neurophysiol. 2007; 118: 910-7.10.1016/j.clinph.2006.11.016]Open DOISearch in Google Scholar
[17. Clemens B, Menes A, Piros P, Bessenyei M, Altmann A, Jerney J, et al. Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings. Epilepsy Res. 2006; 70:190-9.10.1016/j.eplepsyres.2006.05.003]Open DOISearch in Google Scholar
[18. Salinsky MC, Oken BS, Storzbach D, Dodrill CB. Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia. 2003; 44: 1042-50.10.1046/j.1528-1157.2003.60602.x]Search in Google Scholar
[19. Neufeld MY, Kogan E, Chistik V, Korczyn AD. Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy. Clin Neuropharmacol. 1999; 22:80-6.10.1097/00002826-199903000-00003]Search in Google Scholar
[20. Drake ME, Padamadan H, Newell SA. Interictal quantitative EEG in epilepsy. Seizure. 1998; 7:39-42.10.1016/S1059-1311(98)90006-1]Search in Google Scholar
[21. Salinsky MC, Oken BS, Morehead L. Intraindividual analysis of antiepileptic drug effects on EEG background rhythms. Electroencephalogr Clin Neurophysiol. 1994 ; 90:186-93.10.1016/0013-4694(94)90090-6]Open DOISearch in Google Scholar
[22. Herkes GK, Lagerlund TD, Sharbrough FW, Eadie MJ. Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients. J Clin Neurophysiol. 1993; 10:210-6.10.1097/00004691-199304000-00008]Search in Google Scholar
[23. Besser R, Hornung K, Theisohn M, Rothacher G, Kramer G. EEG changes in patients during the introduction of carbamazepine. Electroencephalogr Clin Neurophysiol. 1992; 83:19-23.10.1016/0013-4694(92)90128-5]Open DOISearch in Google Scholar
[24. Kalviainen R, Aikia M, Partanen J, Sivenius J, Mumford J, Saksa M, et al. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. J Child Neurol. 1991; Suppl 2: 60-9.10.1177/0883073891006002111]Search in Google Scholar
[25. Miyauchi T, Endo K, Yamaguchi T, Hagimoto H. Computerized analysis of EEG background activity in epileptic patients. Epilepsia. 1991; 32:870-81.10.1111/j.1528-1157.1991.tb05544.x]Open DOISearch in Google Scholar
[26. Fonseca LC, Tedrus GM, Chiodi MG, Cerqueira JN, Duran MH. Quantitative electroencephalography in children with benign childhood epilepsy with centrotemporal spikes: analysis of band power. Arq Neuropsiquiatr. 2004; 62:455-8.10.1590/S0004-282X2004000300014]Search in Google Scholar
[27. Camfield P, Gordon K, Camfield C, Tibbles J, Dooley J, Smith B. EEG results are rarely the same if repeated within six months in childhood epilepsy. Can J Neurol Sci. 1995; 22:297-300.10.1017/S0317167100039512]Open DOISearch in Google Scholar
[28. Konishi T, Naganuma Y, Hongou K, Murakami M, Yamatani M, Okada T. Effects of antiepileptic drugs on EEG background activity in children with epilepsy: initial phase of therapy. Clin Electroencephalogr. 1995; 26:113-9.10.1177/155005949502600209]Search in Google Scholar
[29. Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of the epilipsies and epileptic syndromes. Epilepsia, 1989; 30:389-99.10.1111/j.1528-1157.1989.tb05316.x]Search in Google Scholar
[30. American EEG Society Guidelines in EEG, 1-7, 13 (Revised 1994). J Clin Neurophysiol. 1994; 11: 1-143. ]Search in Google Scholar
[31. Harmony T, Hinojosa G, Marosi E, Becker J, Rodriguez M, Reyes A, et al. Correlation between EEG spectral parameters and educational evaluation. Inter J Neurosci. 1990; 54:147-55.10.3109/00207459008986630]Search in Google Scholar
[32. Benninger C, Matthis P, Scheffner D. EEG development of healthy boys and girls. Results of a longitudinal study. Electroencephalogr Clin Neurophysiol. 1984; 57:1-12.10.1016/0013-4694(84)90002-6]Search in Google Scholar
[33. Niedermeyer E. Maturation of the EEG: development of waking and sleep patterns. In: Electroencephalography. Basic Principles, Clinical Applications and Related Fields. Niedermeyer E, Lopes Da Silva F, editors. Urban & Schvarzenberg, 1983, p. 107-30.]Search in Google Scholar
[34. Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bulletin. 1945; 1: 80-3.10.2307/3001968]Search in Google Scholar
[35. Genton P, McMenamin J. Aggravation of seizure by antiepileptic drugs: what to do in clinical practice. Epilepsia. 1998; 39:26-9.10.1111/j.1528-1157.1998.tb05119.x9593233]Open DOISearch in Google Scholar
[36. Frost JD Jr, Hrachovy RA, Glaze DG, Rettig GM. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. Clin Neurophysiol. 1995; 1:57-63.]Search in Google Scholar
[37. Wu X, Xiao CH. Quantitative pharmaco-EEG of carbamazepine in volunteers and epileptics. Clin Electroencephalogr. 1996; 27:40-5.10.1177/1550059496027001078719501]Search in Google Scholar
[38. Khachidze I, Maloletnev V, Mamukashvili M. Effect of the sodium valproate on EEG pattern in epileptic patients. Proc Georgian Acad Sci. 2006; 5:1109-14.]Search in Google Scholar
[39. Salinsky MC, Binder LM, Oken BS, Storzbach D, Aron CR, Dodrill CB. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia. 2002; 5:482-90.10.1046/j.1528-1157.2002.22501.x12027908]Search in Google Scholar
[40. Garcia-Borreguero D, Bronisch T, Apelt S, Yassouridis A, Emrich H M. Treatment of benzodiazepine withdrawal symptoms with carbamazepine. Eur Arch Psychiatry Clin Neurosci. 1991; 3:145-50.10.1007/BF022197131686406]Open DOISearch in Google Scholar
[41. Stefan H, Fraunberger B. Valproate sustained release in the treatment of epilepsy. Fortschr Neurol Psychiatr. 2005; 73:681-6.10.1055/s-2004-83029916283612]Search in Google Scholar
[42. Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther. 2006; 2:790-8.10.1124/jpet.106.10496816895979]Search in Google Scholar
[43. Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 2005; 63:141-9.10.1016/j.eplepsyres.2005.02.00215777732]Open DOISearch in Google Scholar
[44. Goyal V, Bhatia M, Behari M. Increased depressant effect of phenytoin sodium as compared to carbamazepine on cortical excitability. J Transcranial Magnetic Evaluation. 2004; 2: 224-7.]Search in Google Scholar
[45. Kochen S, Giagante B, Oddo S. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine. Eur J Neurology. 2002; 9:41-7.10.1046/j.1468-1331.2002.00317.x11784375]Search in Google Scholar
[46. Talwar D, Arora MS, Sher PK. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia. 1994; 35:1154-9.10.1111/j.1528-1157.1994.tb01782.x7988504]Open DOISearch in Google Scholar
[47. Guerrini R, Belmonte A, Genton P. Antiepileptic druginduced worsening of seizures in children. Epilepsia. 1998; 39(Suppl 3):2-10.10.1111/j.1528-1157.1998.tb05118.x9593229]Search in Google Scholar
[48. Stefan H, Lopes da Silva FH, Löscher W, Schmidt D, Perucca E, Brodie MJ. et al. Epileptogenesis and rational therapeutic strategies. Acta Neurol Scand. 2006; 113:139-55.10.1111/j.1600-0404.2005.00561.x16441243]Search in Google Scholar